These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 12939341)

  • 1. A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition.
    Macdonald WA; Purcell AW; Mifsud NA; Ely LK; Williams DS; Chang L; Gorman JJ; Clements CS; Kjer-Nielsen L; Koelle DM; Burrows SR; Tait BD; Holdsworth R; Brooks AG; Lovrecz GO; Lu L; Rossjohn J; McCluskey J
    J Exp Med; 2003 Sep; 198(5):679-91. PubMed ID: 12939341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the peptide binding motif for HLA-B44, one of the most common HLA-B alleles in the Caucasian population.
    DiBrino M; Parker KC; Margulies DH; Shiloach J; Turner RV; Biddison WE; Coligan JE
    Biochemistry; 1995 Aug; 34(32):10130-8. PubMed ID: 7543776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in the recognition by CTL of peptides presented by the HLA-B*4402 and the HLA-B*4403 molecules which differ by a single amino acid.
    Herman J; Jongeneel V; Kuznetsov D; Coulie PG
    Tissue Antigens; 1999 Feb; 53(2):111-21. PubMed ID: 10090611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of human leukocyte antigen (HLA) micropolymorphism on ligand specificity within the HLA-B*41 allotypic family.
    Bade-Döding C; Theodossis A; Gras S; Kjer-Nielsen L; Eiz-Vesper B; Seltsam A; Huyton T; Rossjohn J; McCluskey J; Blasczyk R
    Haematologica; 2011 Jan; 96(1):110-8. PubMed ID: 20934997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of natural peptide ligands for HLA-B*4402 and -B*4403: implications for peptide involvement in allorecognition of a single amino acid change in the HLA-B44 heavy chain.
    Fleischhauer K; Avila D; Vilbois F; Traversari C; Bordignon C; Wallny HJ
    Tissue Antigens; 1994 Nov; 44(5):311-7. PubMed ID: 7878657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognition.
    Archbold JK; Macdonald WA; Gras S; Ely LK; Miles JJ; Bell MJ; Brennan RM; Beddoe T; Wilce MC; Clements CS; Purcell AW; McCluskey J; Burrows SR; Rossjohn J
    J Exp Med; 2009 Jan; 206(1):209-19. PubMed ID: 19139173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hierarchy of Epstein-Barr virus-specific cytotoxic T-cell responses in individuals carrying different subtypes of an HLA allele: implications for epitope-based antiviral vaccines.
    Khanna R; Burrows SR; Neisig A; Neefjes J; Moss DJ; Silins SL
    J Virol; 1997 Oct; 71(10):7429-35. PubMed ID: 9311821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a dominant self-ligand bound to three HLA B44 alleles and the preliminary crystallographic analysis of recombinant forms of each complex.
    Macdonald W; Williams DS; Clements CS; Gorman JJ; Kjer-Nielsen L; Brooks AG; McCluskey J; Rossjohn J; Purcell AW
    FEBS Lett; 2002 Sep; 527(1-3):27-32. PubMed ID: 12220628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of microvariant-specific CTL lines reactive to a single amino acid mismatch in bulk cultures using a transfectant expressing a single HLA class I molecule.
    Cereb N; Yang SY
    J Immunol; 1996 Jan; 156(1):18-26. PubMed ID: 8598460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential differences in ligand presentation and T cell epitope recognition among HLA molecules of the HLA-B44 supertype.
    Hillen N; Mester G; Lemmel C; Weinzierl AO; Müller M; Wernet D; Hennenlotter J; Stenzl A; Rammensee HG; Stevanović S
    Eur J Immunol; 2008 Nov; 38(11):2993-3003. PubMed ID: 18991276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of recognition of HLA class I mismatches outside α1/α2 domains by CD8+ alloreactive T lymphocytes: the HLA-B44 paradigm.
    Bettens F; Schanz U; Tiercy JM
    Tissue Antigens; 2013 Jun; 81(6):414-8. PubMed ID: 23488546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous prediction of binding capacity for multiple molecules of the HLA B44 supertype.
    Sidney J; Southwood S; Pasquetto V; Sette A
    J Immunol; 2003 Dec; 171(11):5964-74. PubMed ID: 14634108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognition.
    Theodossis A; Guillonneau C; Welland A; Ely LK; Clements CS; Williamson NA; Webb AI; Wilce JA; Mulder RJ; Dunstone MA; Doherty PC; McCluskey J; Purcell AW; Turner SJ; Rossjohn J
    Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5534-9. PubMed ID: 20212169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structures of two peptide-HLA-B*1501 complexes; structural characterization of the HLA-B62 supertype.
    Røder G; Blicher T; Justesen S; Johannesen B; Kristensen O; Kastrup J; Buus S; Gajhede M
    Acta Crystallogr D Biol Crystallogr; 2006 Nov; 62(Pt 11):1300-10. PubMed ID: 17057332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The polymorphism at residue 156 determines the HLA-B*35 restricted peptide repertoire during HCMV infection.
    Abels WC; Manandhar T; Kunze-Schumacher H; Blasczyk R; Bade-Döding C
    Immunogenetics; 2018 Nov; 70(10):639-646. PubMed ID: 30128813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA class I-associated diseases with a suspected autoimmune etiology: HLA-B27 subtypes as a model system.
    Uchanska-Ziegler B; Loll B; Fabian H; Hee CS; Saenger W; Ziegler A
    Eur J Cell Biol; 2012 Apr; 91(4):274-86. PubMed ID: 21665321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational dimorphism of self-peptides and molecular mimicry in a disease-associated HLA-B27 subtype.
    Rückert C; Fiorillo MT; Loll B; Moretti R; Biesiadka J; Saenger W; Ziegler A; Sorrentino R; Uchanska-Ziegler B
    J Biol Chem; 2006 Jan; 281(4):2306-16. PubMed ID: 16221670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell allorecognition via molecular mimicry.
    Macdonald WA; Chen Z; Gras S; Archbold JK; Tynan FE; Clements CS; Bharadwaj M; Kjer-Nielsen L; Saunders PM; Wilce MC; Crawford F; Stadinsky B; Jackson D; Brooks AG; Purcell AW; Kappler JW; Burrows SR; Rossjohn J; McCluskey J
    Immunity; 2009 Dec; 31(6):897-908. PubMed ID: 20064448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-B44 subtyping in the Catalan population using reference strand mediated conformation analysis. Implications for the selection of unrelated bone marrow donors.
    Gallardo D; Aróstegui JI; Rodríguez-Luaces M; Querol S; González JR; García-López J; Grañena A
    Tissue Antigens; 2000 Aug; 56(2):173-7. PubMed ID: 11019921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of a SARS coronavirus-derived peptide bound to the human major histocompatibility complex class I molecule HLA-B*1501.
    Røder G; Kristensen O; Kastrup JS; Buus S; Gajhede M
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 Jun; 64(Pt 6):459-62. PubMed ID: 18540051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.